Nimesulide in the Treatment of Pelvic Inflammatory Diseases

A Chiàntera, R Tesauro, S. Di Leo, Mariaclaudia Meli, I. Scaricabarozzi
In: Drugs · 1993 · vol. 46(Supplement 1) , pp. 134–136 · doi:10.2165/00003495-199300461-00029 · PMID:7506152 · W1969564774
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-08, 2026-08-01 ⓘ

This multicenter study assessed nimesulide's efficacy and tolerability in 400 patients with various gynecological inflammatory diseases, finding significant symptom improvement and good tolerability across all conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

400 patients aged 18 to 71 years took part in a multicentre noncomparative study designed to assess the clinical efficacy and tolerability of nimesulide in gynaecological inflammatory disease: adnexitis (72 patients), cervicitis (78 patients), endometritis (18 patients), myometritis (22 patients), and combined disorders (210 patients). All patients were treated with nimesulide 100mg twice daily in granular form for an average of 19.5 days. The treatment produced good results in all types of diseases considered, with a significant decrease in severity of symptoms being observed. The drug was well tolerated.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (8)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK